Frontiers in Immunology (Sep 2021)

Long Non-Coding RNAs as Biomarkers and Therapeutic Targets in Sepsis

  • Chuqiao Wang,
  • Chuqiao Wang,
  • Guorui Liang,
  • Jieni Shen,
  • Haifan Kong,
  • Donghong Wu,
  • Jinxiang Huang,
  • Xuefeng Li,
  • Xuefeng Li

DOI
https://doi.org/10.3389/fimmu.2021.722004
Journal volume & issue
Vol. 12

Abstract

Read online

Sepsis, an infection-induced systemic inflammatory disorder, is often accompanied by multiple organ dysfunction syndromes with high incidence and mortality rates, and those who survive are often left with long-term sequelae, bringing great burden to social economy. Therefore, novel approaches to solve this puzzle are urgently needed. Previous studies revealed that long non-coding RNAs (lncRNAs) have exerted significant influences on the process of sepsis. The aim of this review is to summarize our understanding of lncRNAs as potential sepsis-related diagnostic markers and therapeutic targets, and provide new insights into the diagnosis and treatment for sepsis. In this study, we also introduced the current diagnostic markers of sepsis and discussed their limitations, while review the research advances in lncRNAs as promising biomarkers for diagnosis and prognosis of sepsis. Furthermore, the roles of lncRNAs in sepsis-induced organ dysfunction were illustrated in terms of different organ systems. Nevertheless, further studies should be carried out to elucidate underlying molecular mechanisms and pathological process of sepsis.

Keywords